MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-11-2026
DaVita Revenue 2011-2026 | DVA
Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.
Traditionally defined as follows:Revenue = Price * Quantity of productsRevenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]
This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.
Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.
Annual Revenue DaVita
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.6 B | 12.8 B | 12.1 B | 11.6 B | 11.6 B | 11.6 B | 11.4 B | 11.4 B | 10.9 B | 14.7 B | 13.8 B | 12.8 B | 11.8 B | 8.19 B | 6.98 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 14.7 B | 6.98 B | 11.7 B |
Quarterly Revenue DaVita
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.38 B | 3.22 B | - | 3.26 B | 3.19 B | 3.07 B | - | 3.12 B | 3 B | 2.87 B | - | 2.95 B | 2.93 B | 2.82 B | - | 2.94 B | 2.92 B | 2.82 B | 2.91 B | 2.92 B | 2.88 B | 2.84 B | 2.9 B | 2.9 B | 2.84 B | 2.74 B | 2.82 B | 2.85 B | 2.89 B | 2.85 B | 2.78 B | 2.77 B | 2.7 B | 2.63 B | - | 4.24 M | -505 K | 1.39 M | - | 2.78 M | 5.03 M | 2.91 M | - | 5.22 M | 6.1 M | 7.37 M | - | 9.22 M | 7.65 M | 9.37 M | - | 3.06 M | 2.62 M | 2.63 M | - | 2.62 M | 2.42 M | 1.52 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.38 B | -505 K | 1.83 B |
References
- Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).
Revenue of other stocks in the Care facilities industry
| Issuer | Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
The Joint Corp.
JYNT
|
101 M | $ 8.45 | -0.47 % | $ 122 M |  USA |
 |
Amedisys
AMED
|
2.35 B | - | 0.01 % | $ 3.3 B | USA |
 |
Мать и Дитя
MDMG
|
25.2 B | - | - | - |  Russia |
 |
Apollo Medical Holdings
AMEH
|
1.39 B | - | -2.11 % | $ 1.84 B | USA |
 |
Chemed Corporation
CHE
|
2.43 B | $ 372.07 | -0.38 % | $ 5.59 B | USA |
 |
Acadia Healthcare Company
ACHC
|
3.15 B | $ 22.33 | -3.64 % | $ 2.05 B | USA |
 |
Community Health Systems
CYH
|
12.5 B | $ 2.91 | -2.18 % | $ 389 M | USA |
 |
Avalon GloboCare Corp.
AVCO
|
1.33 M | - | 26.45 % | $ 70.6 M | USA |
 |
Encompass Health Corporation
EHC
|
5.94 B | $ 97.53 | 0.04 % | $ 9.8 B | USA |
 |
Genesis Healthcare, Inc.
GEN
|
3.91 B | - | - | $ 68.1 M | USA |
 |
MEDNAX
MD
|
1.91 B | $ 20.74 | 0.58 % | $ 1.74 B | USA |
 |
Aesthetic Medical International Holdings Group Limited
AIH
|
902 M | - | 10.96 % | $ 46.2 M |  China |
 |
Capital Senior Living Corporation
CSU
|
384 M | - | -2.09 % | $ 216 M | USA |
 |
Five Star Senior Living Inc.
FVE
|
1.16 B | - | -0.32 % | $ 98.4 M | USA |
|
New Frontier Health Corporation
NFH
|
2.26 B | - | 3.54 % | $ 1.5 B | USA |
 |
AMN Healthcare Services
AMN
|
3.79 B | $ 18.45 | 0.33 % | $ 723 M | USA |
 |
American Shared Hospital Services
AMS
|
28.3 M | $ 1.98 | - | $ 12.9 M | USA |
 |
National HealthCare Corporation
NHC
|
1.52 B | $ 160.35 | -0.87 % | $ 2.48 B | USA |
 |
Hanger
HNGR
|
1.12 B | - | - | $ 732 M | USA |
 |
Concord Medical Services Holdings Limited
CCM
|
486 M | $ 3.7 | - | $ 485 M | China |
 |
Option Care Health
OPCH
|
5.65 B | $ 28.78 | 1.28 % | $ 4.67 B | USA |
 |
Phibro Animal Health Corporation
PAHC
|
1.3 B | $ 52.98 | -1.52 % | $ 2.15 B | USA |
 |
LHC Group
LHCG
|
2.28 B | - | - | $ 5.27 B | USA |
 |
Brookdale Senior Living
BKD
|
3.19 B | $ 13.73 | -1.19 % | $ 3.23 B | USA |
 |
Elanco Animal Health Incorporated
ELAN
|
4.72 B | $ 24.29 | -0.65 % | $ 12.1 B | USA |
 |
Addus HomeCare Corporation
ADUS
|
1.42 B | $ 98.74 | -1.04 % | $ 1.78 B | USA |
|
Novo Integrated Sciences
NVOS
|
13.3 M | - | -13.87 % | $ 1.52 M | USA |
 |
Select Medical Holdings Corporation
SEM
|
5.45 B | $ 16.27 | 0.03 % | $ 2 B | USA |
 |
Surgery Partners
SGRY
|
3.31 B | $ 12.05 | 0.58 % | $ 1.53 B | USA |
 |
The Ensign Group
ENSG
|
5.06 B | $ 201.06 | -0.68 % | $ 11.5 B | USA |
|
Sanara MedTech
SMTI
|
65 M | $ 17.84 | -2.75 % | $ 148 M | USA |
 |
HCA Healthcare
HCA
|
75.6 B | $ 478.71 | -3.22 % | $ 113 B | USA |
 |
Healthcare Services Group
HCSG
|
1.84 B | $ 19.54 | 0.03 % | $ 1.41 B | USA |
 |
IMAC Holdings
IMAC
|
72 K | - | -1.77 % | $ 25.4 M | USA |
 |
Universal Health Services
UHS
|
17.4 B | $ 185.0 | -1.67 % | $ 11.8 B | USA |
 |
ModivCare
MODV
|
2.79 B | - | -25.23 % | $ 6.12 M | USA |
 |
U.S. Physical Therapy
USPH
|
781 M | $ 74.44 | -1.06 % | $ 1.13 B | USA |
 |
Oak Street Health
OSH
|
578 M | - | 0.03 % | $ 9.53 B | USA |
 |
Tenet Healthcare Corporation
THC
|
21.3 B | $ 197.86 | -2.73 % | $ 17.8 B | USA |
 |
Ontrak
OTRK
|
10.8 M | - | -11.98 % | $ 1.53 M | USA |
 |
Fresenius Medical Care AG & Co. KGaA
FMS
|
19.6 B | $ 22.0 | 0.5 % | $ 7.05 B |  Germany |
 |
Regional Health Properties
RHE
|
18.3 M | - | - | $ 5.2 M | USA |
 |
SunLink Health Systems
SSY
|
32.4 M | - | 17.98 % | $ 7.81 M | USA |
 |
Tivity Health
TVTY
|
481 M | - | 0.09 % | $ 1.6 B | USA |
 |
The Pennant Group
PNTG
|
948 M | $ 31.32 | -0.18 % | $ 1.08 B | USA |